Shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eleven ratings firms that are currently covering the stock, Marketbeat Ratings reports. Four analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The […]